Tech Center 1600 • Art Units: 1615 1621 1627
This examiner grants 55% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18683029 | HUMAN MILK OLIGOSACCHARIDES IN SULFATE-FREE CLEANSING COMPOSITIONS | Non-Final OA | DSM IP ASSETS B.V. |
| 17845017 | ORAL PRODUCT TABLET AND METHOD OF MANUFACTURE | Final Rejection | NICOVENTURES TRADING LIMITED |
| 18547550 | PESTICIDAL FORMULATIONS | Final Rejection | SYNGENTA CROP PROTECTION AG |
| 17996618 | LIPID NANOPARTICLE (LNP) DELIVERY SYSTEMS AND USES THEREOF | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17772709 | OXYGEN-GENERATING WOUNDING HEALING DRESSING | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18637039 | LONG-WEAR COMPOSITIONS | Non-Final OA | L'OREAL |
| 18258911 | COSMETIC COMPOSITION COMPRISING A COPOLYMER BASED ON ACETOACETATE FUNCTIONS | Non-Final OA | L'OREAL |
| 18037684 | MULTICOMPARTMENT CONDUCTIVE COLLAGEN SCAFFOLD AND RELATED METHODS OF MAKING AND USING THE SAME | Non-Final OA | University of Virginia Patent Foundation |
| 18197957 | POLYMER NANOPARTICLE, METHOD FOR THE MANUFACTURE THEREOF, AND METHOD FOR INTRACELLULAR DELIVERY OF A CARGO | Final Rejection | UNIVERSITY OF MASSACHUSETTS |
| 18584761 | COMPOSITION INCLUDING A METAL-ORGANIC FRAMEWORK (MOF) NANOPARTICLE FOR ORAL PROTEIN ADMINISTRATION | Non-Final OA | WUHAN UNIVERSITY |
| 18289661 | Lipid Nanoparticle-Mediated mRNA Delivery to the Pancreas | Non-Final OA | Carnegie Mellon University |
| 18188154 | PHOSPHOLIPID PRESENTING PARTICLES FOR CELL TARGETING IN THERAPY AND DIAGNOSTICS | Non-Final OA | UNIVERSITY OF SOUTH CAROLINA |
| 18179191 | DISINFECTING FORMULATIONS WITH CARVACROL | Non-Final OA | THE CLOROX COMPANY |
| 18553658 | PESTICIDAL MIXTURES | Non-Final OA | ADAMA MAKHTESHIM LTD. |
| 18698365 | METHOD FOR PREPARING LIPID NANOPARTICLES | Non-Final OA | leon-nanodrugs GmbH |
| 18624168 | PREPARATION METHOD FOR SILICON DIOXIDE, AND TOOTHPASTE | Non-Final OA | Jinsanjiang (Zhaoqing) Silicon Material Co., LTD. |
| 18693229 | COSMETIC PREPARATION CONTAINING LIME GLASS BEADS WITH HIGH SPECIFIC WEIGHT | Non-Final OA | BEIERSDORF AG |
| 18273581 | THERMALLY STABLE, MINERAL OIL-FREE W/O EMULSION | Non-Final OA | BEIERSDORF AG |
| 18688910 | Methods and Compositions for Growing Plants | Non-Final OA | GreenTech Ventures, Inc. |
| 18688519 | COMPOSITIONS AND METHODS FOR TARGETED DEGRADATION OF PROTEINS IN A PLANT CELL | Non-Final OA | Oerth Bio LLC |
| 18577176 | COMPOSITIONS, METHODS AND SYSTEMS FOR AEROSOL DRUG DELIVERY | Non-Final OA | ASTRAZENECA PHARMACEUTICALS LP |
| 18686065 | LYOPHILISED FORMULATIONS OF mRNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES | Non-Final OA | GENNOVA BIOPHARMACEUTICALS LTD. |
| 18684222 | ANHYDROUS TOPICAL DELIVERY SYSTEM FOR LIPID, AQUEOUS, AND ALCOHOL SOLUBILIZED ACTIVES | Non-Final OA | Morse Laboratories L.P. |
| 18332826 | Monolithic Implantable Device for Sustained Release of an Antibody | Final Rejection | Celanese EVA Performance Polymers LLC |
| 17971282 | PHARMACEUTICAL COMPOSITIONS WITH ENHANCED STABILITY PROFILES | Non-Final OA | AQUESTIVE THERAPEUTICS, INC. |
| 18573401 | SONOSENSITIVE COMPOSITION | Non-Final OA | Institut National de la Santé et de la Recherche Médicale |
| 18280382 | PHARMACEUTICAL COMPOSITION, AND APREPITANT INJECTION AND FREEZE-DRIED POWDER INJECTION | Final Rejection | WISDOM PHARMACEUTICAL CO., LTD. GUANGZHOU BRANCH |
| 18569188 | METHODS OF CREATING A SLURRY USING LIPOSOME EMULSIONS | Non-Final OA | Brixton Biosciences, Inc. |
| 17919415 | INJECTABLE OIL-BASED PHARMACEUTICAL COMPOSITION | Final Rejection | NANEXA AB |
| 18564780 | Method for Producing an Ionizable Lipid | Non-Final OA | NanoVation Therapeutics Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy